Idorsia Ltd/Fr. IDIA
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Idorsia Ltd
Idorsia Ltd is a pharmaceutical company based in Allschwil, Switzerland. The company focuses on the discovery, development, and commercialization of innovative medicines for a variety of therapeutic areas, including cardiovascular, central nervous system, immunological, and orphan diseases. It emerged as an independent entity in 2017 following the demerger from Actelion Ltd after Johnson & Johnson acquired Actelion. Idorsia's development pipeline includes a range of products in clinical trials, highlighting its commitment to addressing unmet medical needs. With a strategic emphasis on expanding its research footprint, Idorsia leverages its expertise in drug discovery and clinical development to secure a stable competitive position in the biopharmaceutical industry.
Ticker
Fr. IDIA
Sector
Primary listing
XSWX
Employees
650
Headquarters
Allschwil, Switzerland
Website
Idorsia Ltd Metrics
BasicAdvanced
CHF 792M
-
-CHF 0.52
1.75
-
Price and volume
Market cap
CHF 792M
Beta
1.75
52-week high
CHF 4.85
52-week low
CHF 0.85
Average daily volume
2M
Financial strength
Current ratio
1.391
Quick ratio
0.814
Long term debt to equity
-110.762
Total debt to equity
-111.429
Interest coverage (TTM)
-8.38%
Profitability
EBITDA (TTM)
-99.034
Gross margin (TTM)
44.18%
Net profit margin (TTM)
-50.64%
Operating margin (TTM)
-52.81%
Effective tax rate (TTM)
-5.80%
Revenue per employee (TTM)
CHF 340,000
Management effectiveness
Return on assets (TTM)
-14.98%
Return on equity (TTM)
9.51%
Valuation
Price to revenue (TTM)
3.056
Price to book
-0.69
Price to tangible book (TTM)
-0.68
Price to free cash flow (TTM)
-4.036
Free cash flow yield (TTM)
-24.78%
Free cash flow per share (TTM)
-0.778
Growth
Revenue change (TTM)
96.06%
Earnings per share change (TTM)
-64.12%
3-year revenue growth (CAGR)
31.46%
3-year earnings per share growth (CAGR)
-51.88%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Idorsia Ltd stock?
Idorsia Ltd (IDIA) has a market cap of Fr.792M as of March 18, 2026.
What is the P/E ratio for Idorsia Ltd stock?
The price to earnings (P/E) ratio for Idorsia Ltd (IDIA) stock is 0 as of March 18, 2026.
Does Idorsia Ltd stock pay dividends?
No, Idorsia Ltd (IDIA) stock does not pay dividends to its shareholders as of March 18, 2026.
When is the next Idorsia Ltd dividend payment date?
Idorsia Ltd (IDIA) stock does not pay dividends to its shareholders.
What is the beta indicator for Idorsia Ltd?
Idorsia Ltd (IDIA) has a beta rating of 1.75. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.